Drug Combo Ups Ulcer Risk After Cryoablation in Patients With HCC

Patients with hepatocellular carcinoma should be switched from a PD-1, TKI combination to monotherapy after cryoablation. The study was published as a preprint and has not yet been peer reviewed.
First Look

source https://www.medscape.com/viewarticle/969738?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost